Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TBC1D3P7 is a human pseudogene—DNA that resembles a functional TBC1 domain family member gene but does not encode a protein or known functional RNA[2][3]. Pseudogenes are often nonfunctional due to mutations, loss of regulatory elements, or other genetic alterations. While some pseudogenes transcribe RNA that can participate in regulating gene expression (such as through RNA interference or acting as miRNA sponges), there is no documented evidence that TBC1D3P7 itself has biological activity, disease involvement, or serves as a drug target[2][3][1][4][5]. Pseudogenes, including TBC1D3P7, are sometimes retained in mammalian genomes and may occasionally play indirect regulatory roles, but they are generally considered genomic relics rather than functional gene products[1][4][5].
None; no described mechanisms for drugs targeting this pseudogene
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TBC1 domain family member 3 pseudogene 7 (TBC1D3P7).